Alvotech announces strategic refinancing agreementThe financing will enable Alvotech to improve cost of capital, address upcoming debt maturities in 2025 and enhance its financial flexibility. Yellow Wood Partners completes acquisition of Unilever’s Elida BeautyThe Elida Beauty portfolio includes Q-tips, Caress, Ponds and St. Ives for North America and Europe, as well as Impulse, Noxzema, Monsavon and Timotei. Amphastar announces additional $50M increase to its Share Buyback Program The primary goal of the program is to offset dilution created by the company's equity compensation programs. Yellow Wood Partners’ Suave Brands closes ChapStick purchase The closing of the transaction also resulted in Haleon becoming a shareholder in Suave Brands. Estée Lauder completes Deciem acquisition On May 31, Estée Lauder closed on purchasing the remaining interest by utilizing cash on hand for an estimated $860 million. Dr. Reddy's names Milan Kalawadia CEO North America Kalawadia will be responsible for the company’s North America business and will be based out of the Princeton, N.J. office. Taro shareholders approve merger with Sun Pharma Taro will become a privately held company wholly owned by Sun Pharma and soon after its shares will be de-listed from the NYSE. GSK raises $1.5B from sale of remaining Haleon stake GSK said the sale will enable the company to focus on vaccines, cancer and infectious diseases. Alvotech, Dr. Reddy’s collaborate for biosimilar candidate to Prolia, Xgeva Alvotech will develop and manufacture the product, and Dr. Reddy’s will register and commercialize it in the applicable markets. Hikma enters Spanish generic injectables market In the year to date, Hikma has received 36 product approvals and launched 25 products in Spain. First Previous 7 8 9 10 11 Next Last
